The firm is a contract research, development, and manufacturing organisation (CRDMO) that focuses on innovation. Backed by the private equity giant TPG Capital, it provides comprehensive services throughout the entire drug discovery, development, and manufacturing process for small-molecule new chemical entities (NCEs) to pharmaceutical and biotechnology companies worldwide.